Company: BLNE
Filing Date: 2025-02-05
Form Type: DEF 14A
Source: 0001493152-25-005006
Chunk: 179

Company: Beeline Holdings, Inc.
Filing Date: 2025-02-05
Form: DEF 14A
Chunk 179
---
 outstanding Series B Preferred Stock are excluded from this provision. |
| ● | The                                                                                                                                     
 holders                                                                                                                                 
 of Series C Preferred Stock shall have no voting rights; except that nothing will limit a holder’s voting rights with respect           
 to shares of any other class of the Company’s common stock held from time to time.                                                      |

Issuance of Common Stock

During the nine months ended September 30, 2024, the Company issued 1,764shares of common stock to a director for stock-based compensation of $2,046. The shares were valued for accounting purposes using the closing share price of the Company’s common stock on the date of grant of $1.16per share and issued at $3.05per share. During the nine months ended September 30, 2024, the Company issued 55,738shares of common stock to employees and a consultant for stock-based compensation of $0.1million at $1.21per share.

On September 5, 2024, the Company entered into a Securities Purchase Agreement with a single institutional investor for the sale of 92,815shares of common stock for $1.00per share, and the sale of pre-funded warrants for $0.9999per warrant. The warrants permitted the purchase of 349,227shares of common stock for $0.0001per share. The warrants were exercised on September 6, 2024. The Company used the net proceeds for working capital and general corporate purposes.

On September 29, 2023, pursuant to the DSA (see discussion above), the Company issued to the SPV 296,722shares of common stock and 200,000shares of its Series C Preferred Stock. In exchange for that equity, the Company’s debts to the members of the SPV were reduced by a total of $6.5million.

During the year ended December 31, 2023, the Company issued 162,849shares of common stock to directors and employees for stock-based compensation of $0.7million. The shares were valued for accounting purposes using the closing share price of the Company’s common stock on the date of grant, within the range of $1.29to $7.40per share and issued within the range of $3.05to $7.40per share

During the year ended December 31, 2023, the Company sold 343,495shares of common stock for net proceeds of $1.4million in at-the-market public